[Administration of fructose-1,6-diphosphate to the mother by intravenous route and repercussion on the maternal-fetal status].
D000136:Acid-Base Equilibrium; D001034:Apgar Score; D005260:Female; D005315:Fetal Diseases / Q000517:prevention & control*; D005318:Fetal Heart / Q000187:drug effects; D005636:Fructosephosphates / Q000008:administration & dosage*; D006339:Heart Rate / Q000187:drug effects; D006598:Hexosediphosphates / Q000008:administration & dosage*; D006801:Humans; D007231:Infant, Newborn; D007275:Injections, Intravenous; D007743:Labor, Obstetric; D008431:Maternal-Fetal Exchange; D010120:Oxytocics / Q000008:administration & dosage; D011247:Pregnancy; D014599:Uterus / Q000187:drug effects
D005636:Fructosephosphates; D006598:Hexosediphosphates; D010120:Oxytocics
Administración a la madre de fructosa 1-6 difosfato por vía endovenosa y repercusión sobre el estado materno-fetal.